Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Ann Allergy Asthma Immunol. 2020 Jan 13;124(4):342–349. doi: 10.1016/j.anai.2020.01.001

Table 2.

Racial differences in binary allergic outcomes at age 10, before and after covariate adjustment and multiple imputation.

Sensitized to ≥1 sIgE SPT+ Eczema Asthma PC20≤25 mg/ml

Crude N (%)1 Black 223 (62.8%) 222 (77.4%) 83 (24.1%) 86 (25.8%) 181 (56.6%)
White 45 (41.3%) 72 (74.2%) 12 (10.7%) 9 (8.1%) 52 (49.1%)

Adjustment Covariate N OR (95% CI)2 p-value N OR (95% CI)2 p-value N OR (95% CI)2 p-value N OR (95% CI)2 p-value N OR (95% CI)2 p-value
Unadjusted 464 1.85 (1.2, 2.85) <.05 384 0.95 (0.55, 1.65) 0.86 456 2.93 (1.47, 5.84) <.05 444 4.80 (2.23, 10.32) <.05 426 1.28 (0.82, 1.99) 0.23
Household Income 464 2.01 (1.26, 3.21) <.05 384 0.91 (0.5, 1.63) 0.75 456 3.13 (1.52, 6.43) <.05 444 3.97 (1.8, 8.76) <.05 426 1.23 (0.77, 1.98) 0.39
Maternal Education 464 2.17 (1.36, 3.46) <.05 384 1.01 (0.57, 1.8) 0.97 456 3.77 (1.83, 7.79) <.05 444 4.22 (1.92, 9.28) <.05 426 1.26 (0.79, 2.02) 0.34
Maternal Marital Status 464 1.95 (1.23, 3.08) <.05 384 1.07 (0.59, 1.93) 0.82 456 2.79 (1.37, 5.7) <.05 444 4.57 (2.09, 10.01) <.05 426 1.46 (0.91, 2.35) 0.12
Make monthly mortgage or rental payments 422 1.7 (1.08, 2.7) <.05 349 0.83 (0.45, 1.52) 0.55 415 2.52 (1.25, 5.11) <.05 405 4.41 (2.03, 9.6) <.05 385 1.43 (0.89, 2.29) 0.14
Parental history of doctor-diagnosed allergies 397 1.71 (1.06, 2.76) <.05 329 0.8 (0.44, 1.43) 0.45 389 4.01 (1.73, 9.29) <.05 377 5.48 (2.37, 12.68) <.05 361 1.08 (0.67, 1.75) 0.75
Prenatal indoor pet(s) 464 1.65 (1.02, 2.66) <.05 384 0.98 (0.54, 1.79) 0.96 456 2.42 (1.16, 5.06) <.05 444 3.85 (1.73, 8.56) <.05 426 1.32 (0.81, 2.14) 0.27
Prenatal ETS exposure 464 1.86 (1.2, 2.88) <.05 384 0.94 (0.54, 1.63) 0.83 456 2.96 (1.48, 5.93) <.05 444 4.83 (2.24, 10.41) <.05 426 1.27 (0.81, 1.99) 0.30
Prenatal antifungal use 377 2.39 (1.46, 3.89) <.05 310 1.26 (0.69, 2.28) 0.45 370 2.93 (1.37, 6.23) <.05 360 5.44 (2.29, 12.95) <.05 346 1.36 (0.82, 2.26) 0.23
Prenatal antifungal use 377 2.32 (1.43, 3.76) <.05 310 1.27 (0.71, 2.29) 0.42 370 2.62 (1.24, 5.5) <.05 360 5.38 (2.28, 12.71) <.05 346 1.38 (0.84, 2.26) 0.20
Ever breastfed their child 445 1.85 (1.19, 2.87) <.05 369 0.94 (0.55, 1.62) 0.84 437 2.54 (1.29, 5.03) <.05 426 3.88 (1.82, 8.24) <.05 412 1.3 (0.83, 2.02) 0.25
Season of birth 464 1.94 (1.25, 3.02) <.05 384 0.96 (0.55, 1.66) 0.88 456 2.91 (1.46, 5.81) <.05 444 4.95 (2.29, 10.67) <.05 426 1.26 (0.81, 1.97) 0.31
Mode of delivery 463 1.83 (1.18, 2.84) <.05 383 0.94 (0.54, 1.63) 0.82 455 2.85 (1.43, 5.7) <.05 443 4.72 (2.19, 10.17) <.05 425 1.25 (0.8, 1.94) 0.33
Child sex 464 1.89 (1.22, 2.93) <.05 384 0.95 (0.55, 1.64) 0.86 456 2.93 (1.47, 5.86) <.05 444 4.97 (2.3, 10.71) <.05 426 1.29 (0.83, 2.01) 0.26
Maternal age at birth 464 1.96 (1.25, 3.08) <.05 384 0.98 (0.56, 1.72) 0.94 456 3.39 (1.67, 6.87) <.05 444 5.07 (2.33, 11) <.05 426 1.3 (0.82, 2.04) 0.26
Maternal BMI-first measured in pregnancy 437 1.87 (1.19, 2.92) <.05 360 0.91 (0.52, 1.59) 0.74 430 3.67 (1.7, 7.92) <.05 418 5.29 (2.36, 11.84) <.05 400 1.36 (0.86, 2.15) 0.18
Birthweight z-score 441 1.97 (1.22, 3.17) <.05 362 1.22 (0.67, 2.2) 0.52 433 3.4 (1.61, 7.17) <.05 421 3.85 (1.74, 8.5) <.05 404 1.47 (0.89, 2.43) 0.13
Gestational age at delivery 458 2.13 (1.36, 3.35) <.05 377 1.07 (0.61, 1.86) 0.82 449 2.7 (1.35, 5.41) <.05 437 4.08 (1.89, 8.79) <.05 421 1.15 (0.73, 1.8) 0.55
Number of older siblings 464 1.93 (1.24, 2.99) <.05 384 0.94 (0.54, 1.63) 0.82 456 2.98 (1.49, 5.96) <.05 444 4.74 (2.2, 10.21) <.05 426 1.33 (0.85, 2.08) 0.21
Fully Adjusted-Without Imputation 263 2.47 (1.08, 5.63) <.05 215 1.49 (0.53, 4.21) 0.45 258 7.84 (2.2, 27.98) <.05 250 3.79 (1.15, 12.53) <.05 237 2.98 (1.21, 7.34) 0.02
Fully Adjusted-With Imputation 481 2.09 (1.13, 3.84) <.05 481 1.04 (0.5, 2.13) 0.92 481 2.71 (1.13, 6.55) <.05 481 3.00 (1.21, 7.47) <.05 481 2.12 (1.15, 3.92) 0.02
1

Prior to IPW.

2

Odds of specified outcome in black versus white children, respectively. All models use IPWs to account for loss to follow-up.